{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:53:23Z","timestamp":1792792403616,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002002","name":"Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA060553"],"award-info":[{"award-number":["P30 CA060553"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCI R01-CA121192"],"award-info":[{"award-number":["NCI R01-CA121192"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["VA I01CX000916"],"award-info":[{"award-number":["VA I01CX000916"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bneo.2025.100122","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T12:46:21Z","timestamp":1748954781000},"page":"100122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9359-882X","authenticated-orcid":false,"given":"Adam Y.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-2948","authenticated-orcid":false,"given":"Jonathan S.","family":"Rink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1246-0250","authenticated-orcid":false,"given":"Sara","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor J.","family":"Zak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-7912","authenticated-orcid":false,"given":"Yasmin","family":"Abaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas C.","family":"Platanias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-7064","authenticated-orcid":false,"given":"Leo I.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-6213","authenticated-orcid":false,"given":"C. Shad","family":"Thaxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bneo.2025.100122_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2025.100122_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.2023022481","article-title":"How I treat refractory and relapsed acute myeloid leukemia","volume":"143","author":"Thol","year":"2024","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bneo.2025.100122_bib3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.bneo.2025.100122_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12943-023-01889-6","article-title":"Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy","volume":"22","author":"Sauerer","year":"2023","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.bneo.2025.100122_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/BS9.0000000000000016","article-title":"The role of cholesterol metabolism in leukemia","volume":"1","author":"Zhao","year":"2019","journal-title":"Blood Sci"},{"issue":"9","key":"10.1016\/j.bneo.2025.100122_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/cells8090967","article-title":"Targeting metabolic reprogramming in acute myeloid leukemia","volume":"8","author":"Castro","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bneo.2025.100122_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.leukres.2018.01.021","article-title":"Report of the relapsed\/refractory cohort of SWOG S0919: a phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)","volume":"67","author":"Advani","year":"2018","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.bneo.2025.100122_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ajh.23981","article-title":"Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"90","author":"Shadman","year":"2015","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.bneo.2025.100122_bib9","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1073\/pnas.1213657110","article-title":"Biomimetic, synthetic HDL nanostructures for lymphoma","volume":"110","author":"Yang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.bneo.2025.100122_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305212","article-title":"Nanoparticle targeting in chemo-resistant ovarian cancer reveals dual axis of therapeutic vulnerability involving cholesterol uptake and cell redox balance","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.bneo.2025.100122_bib11","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014888","article-title":"Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis","volume":"296","author":"Rink","year":"2021","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.bneo.2025.100122_bib12","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.18632\/oncotarget.14494","article-title":"Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia","volume":"8","author":"McMahon","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bneo.2025.100122_bib13","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1021\/acs.molpharmaceut.7b00710","article-title":"Rational targeting of cellular cholesterol in diffuse large B-cell lymphoma (DLBCL) enabled by functional lipoprotein nanoparticles: a therapeutic strategy dependent on cell of origin","volume":"14","author":"Rink","year":"2017","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.bneo.2025.100122_bib14","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/ja808856z","article-title":"Templated spherical high density lipoprotein nanoparticles","volume":"131","author":"Thaxton","year":"2009","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.bneo.2025.100122_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/14737140.2015.990889","article-title":"Synthetic high-density lipoprotein-like nanoparticles for cancer therapy","volume":"15","author":"Foit","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.bneo.2025.100122_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00466","article-title":"Targeting the SR-B1 receptor as a gateway for cancer therapy and imaging","volume":"7","author":"Mooberry","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bneo.2025.100122_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116381","article-title":"Scavenger receptor BI attenuates oxidized phospholipid-induced pulmonary inflammation","volume":"462","author":"Dunigan-Russell","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"10.1016\/j.bneo.2025.100122_bib18","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1161\/ATVBAHA.107.145474","article-title":"Increased oxidative stress in scavenger receptor BI knockout mice with dysfunctional HDL","volume":"27","author":"Van Eck","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100122_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/03639045.2018.1513026","article-title":"Scavenger receptor class BI (SR-BI) mediates uptake of CPX-351 into K562 leukemia cells","volume":"45","author":"Di","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"issue":"18","key":"10.1016\/j.bneo.2025.100122_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800311","article-title":"GPX4 at the crossroads of lipid homeostasis and ferroptosis","volume":"19","author":"Forcina","year":"2019","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.bneo.2025.100122_bib21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41598-017-18100-8","article-title":"HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma","volume":"8","author":"Bell","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.bneo.2025.100122_bib22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1194\/jlr.M054635","article-title":"Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein","volume":"56","author":"Luthi","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bneo.2025.100122_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcomp.2022.777728","article-title":"LABKIT: labeling and segmentation toolkit for big image data","volume":"4","author":"Arzt","year":"2022","journal-title":"Front Comput Sci"},{"issue":"269","key":"10.1016\/j.bneo.2025.100122_bib24","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"6","key":"10.1016\/j.bneo.2025.100122_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"10.1016\/j.bneo.2025.100122_bib26","doi-asserted-by":"crossref","first-page":"D1138","DOI":"10.1093\/nar\/gkad993","article-title":"BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis","volume":"52","author":"G\u00edslason","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.bneo.2025.100122_bib27","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1182\/blood-2004-01-0395","article-title":"Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells [published correction appears in Blood. 2004;104(10):3020]","volume":"104","author":"Banker","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bneo.2025.100122_bib28","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood-2002-07-2283","article-title":"Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses","volume":"101","author":"Li","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bneo.2025.100122_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24857","article-title":"GPX4 is a potential diagnostic and therapeutic biomarker associated with diffuse large B lymphoma cell proliferation and B cell immune infiltration","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bneo.2025.100122_bib30","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","article-title":"A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis","volume":"10","author":"Zou","year":"2019","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.bneo.2025.100122_bib31","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1158\/0008-5472.CAN-06-4093","article-title":"Cholesterol starvation induces differentiation of human leukemia HL-60 cells","volume":"67","author":"S\u00e1nchez-Mart\u00edn","year":"2007","journal-title":"Cancer Res"},{"issue":"16","key":"10.1016\/j.bneo.2025.100122_bib32","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1158\/1078-0432.CCR-20-0834","article-title":"Differentiation syndrome with ivosidenib and enasidenib treatment in patients with relapsed or refractory IDH-mutated AML: a U.S. Food and Drug Administration systematic analysis","volume":"26","author":"Norsworthy","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.bneo.2025.100122_bib33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/ijlh.13749","article-title":"IER3 (IEX-1) dysregulation serves as a potential prognostic factor in acute myeloid leukemia patients","volume":"44","author":"Ke","year":"2022","journal-title":"Int J Lab Hematol"},{"issue":"W1","key":"10.1016\/j.bneo.2025.100122_bib34","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.bneo.2025.100122_bib35","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies [published correction appears in Nucleic Acids Res. 2022;50(12):7198]","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bneo.2025.100122_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biomaterials.2018.03.013","article-title":"Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy","volume":"167","author":"Deng","year":"2018","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.bneo.2025.100122_bib37","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1021\/acsami.8b01696","article-title":"HDL-AuNPs-BMS nanoparticle conjugates as molecularly targeted therapy for leukemia","volume":"10","author":"Shen","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"issue":"15","key":"10.1016\/j.bneo.2025.100122_bib38","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/bloodadvances.2023009818","article-title":"Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia","volume":"7","author":"Afzal","year":"2023","journal-title":"Blood Adv"},{"issue":"30","key":"10.1016\/j.bneo.2025.100122_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029541","article-title":"Serum high-density lipoprotein cholesterol level has a significant prognostic impact on outcomes of follicular lymphoma patients","volume":"101","author":"Matsuo","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bneo.2025.100122_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106534","article-title":"Low serum cholesterol levels predict inferior prognosis and improve prognostic index scoring for peripheral T-cell lymphoma, unspecified","volume":"103","author":"Tang","year":"2021","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.bneo.2025.100122_bib41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41375-023-02117-2","article-title":"Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia [published correction appears in Leukemia. 2024;38(4):926]","volume":"38","author":"Akiyama","year":"2024","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.bneo.2025.100122_bib42","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1182\/blood-2011-01-326025","article-title":"Do reactive oxygen species play a role in myeloid leukemias? [published correction appears in Blood. 2014;123(5):798]","volume":"117","author":"Hole","year":"2011","journal-title":"Blood"},{"issue":"1-2","key":"10.1016\/j.bneo.2025.100122_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bneo.2025.100122_bib44","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","article-title":"Persister cancer cells: iron addiction and vulnerability to ferroptosis","volume":"82","author":"Rodriguez","year":"2022","journal-title":"Mol Cell"},{"issue":"20","key":"10.1016\/j.bneo.2025.100122_bib45","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.3390\/cancers13205243","article-title":"Activation of vitamin D receptor pathway enhances differentiating capacity in acute myeloid leukemia with isocitrate dehydrogenase mutations","volume":"13","author":"Sabatier","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.bneo.2025.100122_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.celrep.2019.12.055","article-title":"Vitamin D receptor controls cell stemness in acute myeloid leukemia and in normal bone marrow","volume":"30","author":"Paubelle","year":"2020","journal-title":"Cell Rep"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:41:58Z","timestamp":1764121318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328025000573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2950328025000573"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100122","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100122"}}